The FDA will warn about overuse or misuse of semaglutide (Ozempic, Wegovy and Rybelsus) before the end of 2024.

Ṁ1kṀ5.4k

resolved Jan 25

Resolved

ALL

Market context

Medicine

FDA

Get

1,000

to start trading!

🏅 Top traders

#	Trader	Total profit
1		Ṁ304
2		Ṁ148
3		Ṁ82
4		Ṁ81
5		Ṁ31

People are also trading

Will Ozempic / semaglutide be FDA-approved for Alzheimer's before 2030?

28% chance

Will Matt Kaeberlein start taking semaglutide/ozempic by 2030?

41% chance

Will there be a recall of Wegovy/Ozempic before 2035?

75% chance

How many OECD countries will have court ordered semaglutide drugs (e.g., Ozempic) by the end of 2030

Will 10 million Americans be on semaglutide (or yet-to-be-approved equally good or superior alternatives) by the end of 2030?

78% chance

Before 2033, will semaglutide be shown to improve lifespan, when prescribed to overweight people?

83% chance

Ozempic approval is revoked or withdrawn before 2031

6% chance

When will Hims stop selling semaglutide?

Will Retatrutide (new obesity drug) be FDA approved by the end of 2026?

41% chance

Will Semaglutide cost less than $1000 per year before 2031?

Sort by:

We had a 3 mod panel with @CodeandSolder and @Ziddletwix on Discord.

There was a unanimous agreement to resolve no. We considered the warnings against compounded Semaglutide being potentially dangerous, but did not feel they met the criteria established in this market about overuse or misuse. They were more a general warning to be careful with these products in specific forms.

I'm not sure if that should count or not: https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded

@CodeandSolder this feels like a judgement call situation to me. We probably need to do the 3 mod panel thing. Unless there are more warnings out there.